This inventor holds 1 USPTO granted patent. Top assignee: University of South Florida. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Susan E Minton: Innovator in Cancer Treatment
Introduction
Susan E Minton is a prominent inventor based in Tampa, FL (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on improving the effectiveness of chemotherapy by predicting patient responsiveness to treatment.
Latest Patents
Susan E Minton holds a patent for "Methods of predicting responsiveness to chemotherapeutic agents and selecting treatments." This patent outlines methods for predicting the responsiveness of cancer cells to chemotherapy by measuring the level of phosphorylated Stat or the level of expression of Survivin in cancer cells. The methods involve comparing these levels in cancer cells to respective levels in a control. Additionally, the patent provides methods for selecting appropriate chemotherapeutic treatments based on these measurements. Kits for performing these methods are also included in her patent. Furthermore, the patent discloses methods for modulating Survivin-dependent apoptosis in cancer cells.
Career Highlights
Susan E Minton is affiliated with the University of South Florida, where she continues her research and development in cancer therapies. Her work has the potential to significantly impact the way cancer treatments are personalized for patients, leading to better outcomes.
Collaborations
Some of her notable coworkers include Daniel M Sullivan and Eric Bruce Haura, who contribute to her research efforts and advancements in cancer treatment methodologies.
Conclusion
Susan E Minton's innovative work in predicting chemotherapy responsiveness showcases her dedication to improving cancer treatment. Her patented methods represent a significant advancement in personalized medicine, potentially transforming patient care in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
